Torrens I - Search Results

1

A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.

Granadillo M, Vallespi MG, Batte A, Mendoza O, Soria Y, Lugo VM, Torrens I. Granadillo M, et al. Among authors: torrens i. Vaccine. 2011 Jan 29;29(5):920-30. doi: 10.1016/j.vaccine.2010.11.083. Epub 2010 Dec 9. Vaccine. 2011. PMID: 21145912

2

Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors.

Torréns I, Mendoza O, Batte A, Reyes O, Fernández LE, Mesa C, Guillén G. Torréns I, et al. Vaccine. 2005 Dec 30;23(50):5768-74. doi: 10.1016/j.vaccine.2005.07.049. Epub 2005 Aug 8. Vaccine. 2005. PMID: 16112257

3

Expression, purification and characterization of a recombinant fusion protein based on the human papillomavirus-16 E7 antigen.

Granadillo M, Batte A, Lugo VM, Musacchio A, Bequet-Romero M, Betancourt L, Besada V, Javier L, Molina R, Falcón V, Torrens I. Granadillo M, et al. Among authors: torrens i. Springerplus. 2013 Dec;2(1):12. doi: 10.1186/2193-1801-2-12. Epub 2013 Jan 12. Springerplus. 2013. PMID: 23483788 Free PMC article.

4

LALF_32-51-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs.

Granadillo M, Batte A, Blanco A, Alfonso AB, Suárez J, Merino N, Carballo R, González BO, Prieto YC, Varas L, Soler D, Limonta M, Miyares M, Aldana L, Torrens I. Granadillo M, et al. Among authors: torrens i. Clin Exp Metastasis. 2017 Apr;34(3-4):241-249. doi: 10.1007/s10585-017-9846-x. Epub 2017 Apr 17. Clin Exp Metastasis. 2017. PMID: 28417212

5

Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.

Yanez RJR, Lamprecht R, Granadillo M, Weber B, Torrens I, Rybicki EP, Hitzeroth II. Yanez RJR, et al. Among authors: torrens i. PLoS One. 2017 Aug 11;12(8):e0183177. doi: 10.1371/journal.pone.0183177. eCollection 2017. PLoS One. 2017. PMID: 28800364 Free PMC article.

6

Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate.

Granadillo M, Batte A, Alfonso AB, Blanco A, Urquiza D, Varas L, Soler D, Miyares M, Limonta M, Torrens I. Granadillo M, et al. Among authors: torrens i. Vaccine. 2019 Jul 9;37(30):3957-3960. doi: 10.1016/j.vaccine.2019.05.060. Epub 2019 May 30. Vaccine. 2019. PMID: 31155419

7

Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.

Vallespi MG, Fernandez JR, Torrens I, Garcia I, Garay H, Mendoza O, Granadillo M, Falcon V, Acevedo B, Ubieta R, Guillen GE, Reyes O. Vallespi MG, et al. Among authors: torrens i. J Pept Sci. 2010 Jan;16(1):40-7. doi: 10.1002/psc.1192. J Pept Sci. 2010. PMID: 19908203

8

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Solares AM, Baladron I, Ramos T, Valenzuela C, Borbon Z, Fanjull S, Gonzalez L, Castillo D, Esmir J, Granadillo M, Batte A, Cintado A, Ale M, Fernandez de Cossio ME, Ferrer A, Torrens I, Lopez-Saura P. Solares AM, et al. Among authors: torrens i. ISRN Obstet Gynecol. 2011;2011:292951. doi: 10.5402/2011/292951. Epub 2011 Mar 24. ISRN Obstet Gynecol. 2011. PMID: 21748025 Free PMC article.

9

LALF_32-51 -E7, a HPV-16 therapeutic vaccine candidate, forms protein body-like structures when expressed in Nicotiana benthamiana leaves.

Yanez RJR, Lamprecht R, Granadillo M, Torrens I, Arcalís E, Stöger E, Rybicki EP, Hitzeroth II. Yanez RJR, et al. Among authors: torrens i. Plant Biotechnol J. 2018 Feb;16(2):628-637. doi: 10.1111/pbi.12802. Epub 2017 Sep 7. Plant Biotechnol J. 2018. PMID: 28733985 Free PMC article.

10

A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.

Torréns I, Ojalvo AG, Seralena A, Pupo E, Lugo V, Páez R. Torréns I, et al. Biochem Biophys Res Commun. 1999 Dec 9;266(1):230-6. doi: 10.1006/bbrc.1999.1793. Biochem Biophys Res Commun. 1999. PMID: 10581194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters